Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants

NCT00007787 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

350

Enrollment

NIH

Sponsor class

Conditions

Kidney Transplantation
Chronic Allograft Nephropathy

Interventions

BIOLOGICAL: Cyclosporine
BIOLOGICAL: Anti-human thymocyte globulin (rabbit)
DRUG: Tacrolimus

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)